The Xeltis synthetic polymer restorative pulmonary valve is implanted surgically and acts as a scaffold for the patient's own cells to proliferate. The valve and conduit then bioresorbs over time, leaving behind a new valve made from the patient's own cells. The hope is this will reduce or eliminate the need for numerous repeat surgeries as a pediatric patient grows.
July 08, 2021
Xeltis Begins Pivotal Trial for Pulmonary Valve That Grows With the Patient
July 8, 2021 – Xeltis announced it started the first pivotal trial for a synthetic polymer restorative pulmonary valve…
Read More
The Robocath R-One cath lab robotic platform being used in Rouen, France, to guide a cardiac Cath procedure. The system gained European approval in 2019. Robocath is now partnering with Philips France and Rennes University Hospital to develop the robotic system to treat strokes.
July 07, 2021
Robocath, Philips and Rennes University Hospital Codevelop Robotic Stroke Intervention System
July 7, 2021 – Robocath, a company that designs, develops and commercializes cath lab robotic solutions to treat…
Read More
Ultra-fast, less than one-minute scan time, cardiac MRI enables accurate assessment of heart anatomy and function, improves patient comfort, increases access to care, and reduces costs
July 02, 2021
Philips and the Spanish National Center for Cardiovascular Research Collaborate on New Ultra-fast Cardiac MRI Protocol
July 2, 2021 — Philips has participated in an important research project to develop a magnetic resonance (MR) imaging…
Read More
The FDA has cleared Angel Medical Systems' second-generation AngelMed Guardian device. The implantable cardiac device detects and warns patients if they are having an acute coronary syndrome (ACS) event, including silent heart attacks. The new, second-generation device is enhanced with ease-of-use adaptations and an updated, long life battery that could potentially double the life of the implanted device
July 01, 2021
FDA Approves AngelMed Enhanced Real-Time Cardiac Monitor for Acute Coronary Syndrome (ACS) Events
July 1, 2021 — The U.S. Food and Drug Administration (FDA) has cleared the Angel Medical Systems Inc. second-generation…
Read More
Abbott says the Xience fluoropolymer coating interacts with blood proteins in a manner that reduces thrombus formation. This feature makes the stent safer to use for shorter duration DAPT.
June 30, 2021
FDA Clears Xience Stent for One Month DAPT in High Risk Bleeding Patients
June 30, 2021 — Abbott announced its Xience family of drug-eluting coronary stents received U.S. Food and Drug…
Read More
Echocardiography Related COVID-19 Research Presented at ASE 2021
June 29, 2021
Echocardiography Related COVID-19 Research Presented at ASE 2021
June 29, 2021 – A new original science category being featured at the American Society of Echocardiography (ASE) 2021…
Read More
3 Studies Show How Echocardiography is a Key Tool in Women's Health. Getty Images
June 29, 2021
3 Studies Show How Echocardiography is a Key Tool in Women's Health
June 29, 2021 – Three research studies presented at the American Society of Echocardiography (ASE) 2021 virtual meeting…
Read More
Images from the ASE presentation. Left, UEA echo showing focal narrowing of the SCPC anastomosis and the same view on invasive angiography. Right, UAE echo showing complete occlusion of pulmonary artery and angiography showing the same view.
June 29, 2021
Ultrasound Contrast Agents Greatly Aids in Complex Congenital Heart Imaging
June 29, 2021 – Echocardiography with ultrasound enhancing agents (UEAs) has proven to be a valuable imaging procedure…
Read More
New cardiac ultrasound technologies featured at the American Society of Echocardiography 2021 Virtual Meeting include intracardiac ultrasound (ICE) imaging from Biosense Webster (left), and cloud-based, vendor-neutral strain imaging from Epsilon Imaging (right).
June 29, 2021
New Technologies Featured at the American Society of Echocardiography 2021 Virtual Meeting
June 29, 2021 – The virtual exhibit hall at American Society of Echocardiography (ASE) 2021 Scientific Sessions Virtual…
Read More
The balloon inflation to deploy an Edwards Lifesciences Sapien 3 TAVR valve in a failed surgical tricuspid valve. This valve-in-valve (VIV) procedures was performed at Beaumont in a 34-year-old female patient who was determined to be too high of a surgical risk for SAVR.
June 29, 2021
Beaumont Performs Rare Tricuspid Transcatheter Valve-in-valve Procedure
June 29, 2021 – Cardiologists at Beaumont Health successfully replaced a 34-year-old woman’s tricuspid valve in a rare…
Read More
ScImage went live in March at Peak Surgery Center of Avondale, Arizona, and was developed in cooperation with the providers from multispecialty cardiovascular group Peak Heart & Vascular, which has locations in Avondale, Surprise, Ariz., and Flagstaff, Ariz. ScImage’s PICOM365 Cloud provides image review, storage and advanced structured reporting to manage the complex, measurement-centric cardiac catheterization procedures performed in the facilities.
June 29, 2021
Outpatient Cath Lab Adopts PICOM365 Cloud With Hemodynamics 
June 29, 2021 - ScImage Inc.has partnered with National Cardiovascular Management (NCM), a national consulting and…
Read More
CentraCare completed the first structural heart procedure in the world guided by a new 4-D hologram technology developed by EchoPixel. The augmented reality technology aims to reduce reduce procedure time, improve accuracy of the procedure, and reduce risk of complications.
June 28, 2021
First 4D Hologram Guided Structural Heart Procedure Performed for LAA Occlusion
June 28, 2021 — CentraCare, one of the largest health systems in Minnesota, successfully completed the first structural…
Read More
Circle Cardiovascular Imaging Partners With DiA Imaging Analysis to Deliver AI-Based Cardiovascular Imaging Solutions
June 28, 2021
Circle Cardiovascular Imaging Partners With DiA Imaging Analysis to Deliver AI-Based Cardiovascular Imaging Solutions
June 28, 2021 — Circle Cardiovascular Imaging Inc. and DiA Imaging Analysis Ltd. entered into a multi-year partnership…
Read More
Researchers analyzing surveillance data on 518 children and adolescents with MIS-C who were admitted to U.S. hospitals in 2020 fopiund those treated with intravenous immune globulin (IVIG) plus glucocorticoids had a lower risk of new or persistent cardiovascular dysfunction than IVIG alone. Left photo Getty Images, right photo Nemours Children’s Health System.
June 28, 2021
Study Provides MIS-C Treatment Guidance To Avoid Cardiovascular Dysfunction
June 28, 2021 - A recent analysis found that children and adolescents with multisystem inflammatory syndrome in…
Read More
The U.S. Food and Drug Administration (FDA) announced June 25 it has added a warning on the Moderna and Pfizer COVID-19 messenger RNA (mRNA) vaccine fact sheets to explain they may cause myocarditis in rare cases as a side effect. The agency said the side effect is very rare and patients generally recover quickly, but it can disportionally affect younger patients in their teens and early 20s. Getty Images
Dave Fornell, Editor
June 28, 2021
FDA Adds Myocarditis Warning to COVID mRNA Vaccine Clinician Fact Sheets
June 28, 2021 — The U.S. Food and Drug Administration (FDA) announced June 25 it has added a warning on the Moderna and…
Read More
Point of care ultrasound, POCUS, combined with artificial intelligence, can help improve echo image quality by inexperienced sonographers.
June 25, 2021
Artificial Intelligence Guided Point of Care Ultrasound by Novice Users
June 25, 2021 – COVID-19 changed everything in healthcare, and a benefit from this pandemic was a surge in innovations…
Read More
A small number of patients develop myocarditis after receiving the messenger RNA (mRNA) COVID-19 vaccines from Pfizer and Moderna. This recently raised concerns after numbers for this adverse reaction jumped in April and May, prompting review this week by the Centers for Disease Control and Prevention (CDC) Advisory Committee on the Immunization Practices (ACIP).
By Dave Fornell, Editor
June 24, 2021
Overview of Myocarditis Cases Caused by the COVID-19 Vaccine
A small number of patients develop inflammation leading to myocarditis after receiving the messenger RNA (mRNA) COVID-…
Read More
Clinical trial quality data can be derived from national cardiovascular registries, which may change how trials are performed in the future.
June 24, 2021
Study Shows ACC Registry Data Could Support Cardiac Clinical Trials
June 24, 2021 — Data captured in American College of Cardiology (ACC) National Cardiovascular Data Registry (NCDR)…
Read More
Surgical Site Infection (SSI) prevention remains a high priority for cardiac surgeons whose heroic efforts can be thwarted by infection. No matter how skilled a cardiac surgeon or how successful a surgery, when an SSI sets in, patients can find themselves fighting for their lives. While not unique to cardiovascular surgery, post-operative infections have severe repercussions for recovering heart surgery patients. Unfortunately, even with SSI prevention methods implemented, SSIs remain as common as 5% in car
By Noam Emanuel, Ph.D.
June 24, 2021
Rethinking Heart Surgery Surgical Site Infection Prevention
Surgical Site Infection (SSI) prevention remains a high priority for cardiac surgeons whose heroic efforts can be…
Read More
Small Number of Patients Have Myocarditis-like Illness After COVID-19 Vaccination. Photo by Dave Fornell
June 23, 2021
Small Number of Patients Have Myocarditis-like Illness After COVID-19 Vaccination
June 23, 2021 — Findings from a small study detailing the treatment of myocarditis-like symptoms in seven people after…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now